LSB
LakeShore Biopharma
LSB
LSB
Delisted
LSB was delisted on the 19th of September, 2025.
16 hedge funds and large institutions have $15.4M invested in LakeShore Biopharma in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $20.4M → $15.4M (-$5.06M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$150K | |
| 2 | +$44.4K | |
| 3 | +$31.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.1K |
| 5 |
HF
HRT Financial
New York
|
+$14K |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$546K | |
| 3 | -$37K | |
| 4 |
Jane Street
New York
|
-$19.2K |
| 5 |
CS
Clear Street
New York
|
-$160 |